Phenotypic microarrays suggest Escherichia coli ST131 is not a metabolically distinct lineage of extra-intestinal pathogenic E. coli

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Alqasim, Abdulaziz ^a   Emes, Richard ^b,c   Clark, Gemma ^a   Newcombe, Jane ^d   La Ragione, Roberto ^d,e   McNally, Alan ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REAGENT;

ARTICLE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BIOCHEMISTRY; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI ST131; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; GENOME ANALYSIS; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPE; STRAIN DIFFERENCE; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; URINARY TRACT INFECTION;

ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROARRAY ANALYSIS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; URINARY TRACT INFECTIONS;

EID: 84895731855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088374     Document Type: Article

References (41)

1. Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7: 653-660.
2. McCormick A, Fleming D, Charlton J (1995) Morbidity Statistics from General Practice: Fourth National Study 1991-1992. London: HMSO.
3. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, et al. (2005) Urologic diseases in America project: analytical methods and principal findings. J Urol 173: 933-937. (Pubitemid 40239368)
4. Cove-Smith A, Almond M (2007) Management of urinary tract infections in the elderly. Trends Urol Gynaecol Sex Health 12: 31-34.
5. Foxman B (2002) Epidemiology of Urinary Tract Infections: Incidence, Morbidity, and Economic Costs. Am J Med 113: 5-13.
6. Smith JL, Fratamico PM, Gunther NW (2007) Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 4: 134-163. (Pubitemid 47041354)
7. Akram M, Shahid M, Khan AU (2007) Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 6: 1-7.
8. Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A (2009) Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 13: 140-144.
9. Zhang L, Foxman B (2003) Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci 8: e235-244.
10. Croxall G, Weston V, Joseph S, Manning G, Cheetham P, et al. (2011) Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol 60: 102-109.
11. Pitout JDD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extended-spectrum b-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59. (Pubitemid 41418336)
12. Livermore DM, Hawkey PM (2005) CTX-M: Changing the face of ESBLs in the UK. J Antimicrob Chemother 56: 451-454. (Pubitemid 41264119)
13. Peirano G, Pitout JDD (2010) Molecular epidemiology of Escherichia coli producing CTX-M b-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35: 316-321.
14. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, et al. (2008) Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 46: 3900-3905.
15. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
16. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024-1028. (Pubitemid 351524443)
17. Coelho A, Mora A, Mamani R, López C, González-López JJ, et al. (2011) Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 66: 517-526.
18. Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, et al. (2008) UK epidemic Escherichia coli strains A-E, with CTX-M-15 β-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 62: 1241-1244.
19. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M (2010) Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug-Resistant E. coli Infections in the United States. Clin Infect Dis 51: 286-294.
20. Croxall G, Hale J, Weston V, Manning G, Cheetham P, et al. (2011) Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 66: 2501-2508.
21. Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80.
22. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, et al. (2012) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67: 346-356.
23. Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, et al. (2008) Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 46: 1076-1080.
24. Le Bouguénec C, Schouler C (2011) Sugar metabolism, an additional virulence factor in enterobacteria. Int J Med Microbiol 301: 1-6.
25. Pancholi V, Chhatwal GS (2003) Housekeeping enzymes as virulence factors for pathogens. Int J Med Microbiol 293: 391-401. (Pubitemid 38082345)
26. Gibreel TM, Dodgson AR, Cheesbrough J, Bolton FJ, Fox AJ, et al. (2012) High Metabolic Potential May Contribute to the Success of ST131 Uropathogenic Escherichia coli. J Clin Microbiol 50: 3202-3207.
27. Clark G, Paszkiewicz K, Hale J, Weston V, Constantinidou C, et al. (2012) Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections. J Antimicrob Chemother 67: 868-877.
28. McNally A, Cheng L, Harris SR, Corander J (2013) The Evolutionary Path to Extraintestinal Pathogenic, Drug-Resistant Escherichia coli Is Marked by Drastic Reduction in Detectable Recombination within the Core Genome. Genome Biol Evol 5: 699-710.
29. Alhashash F, Weston V, Diggle M, McNally A (2013) Multidrug-Resistant Escherichia coli Bacteremia. Emerg Infect Dis 19: 1699-1701.
30. Homann OR, Cai H, Becker JM, Lindquist SL (2005) Harnessing natural diversity to probe metabolic pathways. PLoS Genet 1: e80.
31. Carver TJ, Rutherford KM, Berriman M, Rajandream M-A, Barrell BG, et al. (2005) ACT: the Artemis comparison tool. Bioinformatics 21: 3422-3423. (Pubitemid 41222448)
32. Sheppard SK, Didelot X, Meric G, Torralbo A, Jolley KA, et al. (2013) Genome-wide association study identifies vitamin B5 biosynthesis as a host specificity factor in Campylobacter. Proc Natl Acad Sci U S A 110: 11923-11927.
33. Rohmer L, Hocquet D, Miller SI (2011) Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol 19: 341-348.
34. Anfora AT, Haugen BJ, Roesch P, Redford P, Welch RA (2007) Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect Immun 75: 5298-5304. (Pubitemid 350033617)
35. Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, et al. (2012) Fucose sensing regulates bacterial intestinal colonization. Nature 492: 113-117.
36. Durso LM, Smith D, Hutkins RW (2004) Measurements of fitness and competition in commensal Escherichia coli and E. coli O157: H7 strains. Appl Environ Microbiol 70: 6466-6472. (Pubitemid 39518552)
37. Bochner BR, Gadzinski P, Panomitros E (2001) Phenotype microarrays for high-throughput phenotypic testing and assay of gene function. Genome research 11: 1246-1255. (Pubitemid 32677299)
38. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, et al. (2009) Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25: H4-ST131 clone. Antimicrob Agents Chemother 53: 4472-4482.
39. Chen SL, Hung C-S, Xu J, Reigstad CS, Magrini V, et al. (2006) Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci U S A 103: 5977-5982.
40. Welch R, Burland V, Plunkett III G, Redford P, Roesch P, et al. (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99: 17020-17024. (Pubitemid 36034091)
41. McNally A, Alhashash F, Collins M, Alqasim A, Paszckiewicz K, et al. (2013) Genomic analysis of extra-intestinal pathogenic Escherichia coli urosepsis. Clin Microbiol Infec 19: E328-334.